Optical Coherence Tomography Morphologic and Fractional Flow Reserve Assessment in Diabetes Mellitus Patients

CompletedOBSERVATIONAL
Enrollment

550

Participants

Timeline

Start Date

March 26, 2015

Primary Completion Date

June 30, 2020

Study Completion Date

February 28, 2021

Conditions
Diabetes MellitusCoronary Artery DiseaseCoronary Atheroscleroses
Interventions
PROCEDURE

Optical Coherence Tomography

Patients aged ≥ 18 years bearing target lesions that fulfil the inclusion criteria and have undergone FFR and OCT imaging as per clinical practice will be enrolled in the study.

Trial Locations (1)

8025 AB

Isala, Zwolle

All Listed Sponsors
collaborator

Isala

OTHER

collaborator

St. Jude Medical Nederland B.V.

INDUSTRY

lead

Diagram B.V.

OTHER

NCT02989740 - Optical Coherence Tomography Morphologic and Fractional Flow Reserve Assessment in Diabetes Mellitus Patients | Biotech Hunter | Biotech Hunter